Advanced Enzyme Technologies Limited - Asset Resilience Ratio
Advanced Enzyme Technologies Limited (ADVENZYMES) has an Asset Resilience Ratio of 37.42% as of September 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. Read ADVENZYMES total liabilities for a breakdown of total debt and financial obligations.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2008–2025)
This chart shows how Advanced Enzyme Technologies Limited's Asset Resilience Ratio has changed over time. See Advanced Enzyme Technologies Limited (ADVENZYMES) shareholders funds for net asset value and shareholders' equity analysis.
Liquid Assets Composition Over Time
This chart breaks down Advanced Enzyme Technologies Limited's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see ADVENZYMES market cap.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | Rs764.24 Million | 4.52% |
| Short-term Investments | Rs5.57 Billion | 32.9% |
| Total Liquid Assets | Rs6.33 Billion | 37.42% |
Asset Resilience Insights
- Very High Liquidity: Advanced Enzyme Technologies Limited maintains exceptional liquid asset reserves at 37.42% of total assets.
- This level provides strong protection against economic uncertainties but may indicate potential for more aggressive growth investments.
- The company has significant short-term investments, indicating active treasury management.
Advanced Enzyme Technologies Limited Industry Peers by Asset Resilience Ratio
Compare Advanced Enzyme Technologies Limited's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
AKZO NOBEL SPONS.ADRS 1/3
F:AKUP |
Specialty Chemicals | 2.16% |
|
Air Products and Chemicals Inc
NYSE:APD |
Specialty Chemicals | 2.49% |
|
Akzo Nobel NV
AS:AKZA |
Specialty Chemicals | 2.16% |
|
Swancor Advanced Materials Co Ltd
SHG:688585 |
Specialty Chemicals | 11.19% |
|
Azelis Group NV
BR:AZE |
Specialty Chemicals | 0.00% |
|
Shenzhen Rongda Photosensitive & Technology Co Ltd
SHE:300576 |
Specialty Chemicals | 9.08% |
|
Jihua Group Corp Ltd
SHG:601718 |
Specialty Chemicals | 0.00% |
|
Jiangxi Guotai Civilian
SHG:603977 |
Specialty Chemicals | 12.39% |
Annual Asset Resilience Ratio for Advanced Enzyme Technologies Limited (2008–2025)
The table below shows the annual Asset Resilience Ratio data for Advanced Enzyme Technologies Limited.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-03-31 | 33.74% | Rs5.47 Billion ≈ $59.16 Million |
Rs16.21 Billion ≈ $175.34 Million |
+0.79pp |
| 2024-03-31 | 32.95% | Rs5.06 Billion ≈ $54.72 Million |
Rs15.35 Billion ≈ $166.05 Million |
+3.22pp |
| 2023-03-31 | 29.73% | Rs4.23 Billion ≈ $45.72 Million |
Rs14.22 Billion ≈ $153.77 Million |
+14.73pp |
| 2022-03-31 | 15.00% | Rs1.90 Billion ≈ $20.56 Million |
Rs12.68 Billion ≈ $137.09 Million |
-2.44pp |
| 2021-03-31 | 17.43% | Rs2.01 Billion ≈ $21.73 Million |
Rs11.53 Billion ≈ $124.66 Million |
+1.34pp |
| 2020-03-31 | 16.09% | Rs1.57 Billion ≈ $17.03 Million |
Rs9.79 Billion ≈ $105.83 Million |
-0.63pp |
| 2019-03-31 | 16.72% | Rs1.36 Billion ≈ $14.67 Million |
Rs8.11 Billion ≈ $87.72 Million |
+8.11pp |
| 2018-03-31 | 8.61% | Rs629.94 Million ≈ $6.81 Million |
Rs7.32 Billion ≈ $79.12 Million |
+7.24pp |
| 2017-03-31 | 1.37% | Rs78.73 Million ≈ $851.44K |
Rs5.77 Billion ≈ $62.35 Million |
+5.37pp |
| 2016-03-31 | -4.01% | Rs-180.44 Million ≈ $-1.95 Million |
Rs4.51 Billion ≈ $48.72 Million |
-0.15pp |
| 2015-03-31 | -3.86% | Rs-160.34 Million ≈ $-1.73 Million |
Rs4.16 Billion ≈ $44.98 Million |
+0.33pp |
| 2014-03-31 | -4.19% | Rs-170.05 Million ≈ $-1.84 Million |
Rs4.06 Billion ≈ $43.92 Million |
-4.19pp |
| 2013-03-31 | 0.00% | Rs-2.00K ≈ $-21.61 |
Rs3.96 Billion ≈ $42.83 Million |
-0.16pp |
| 2010-03-31 | 0.16% | Rs1.76 Million ≈ $19.03K |
Rs1.09 Billion ≈ $11.80 Million |
+0.13pp |
| 2009-03-31 | 0.03% | Rs280.00K ≈ $3.03K |
Rs940.41 Million ≈ $10.17 Million |
-0.09pp |
| 2008-03-31 | 0.12% | Rs1.13 Million ≈ $12.22K |
Rs906.55 Million ≈ $9.80 Million |
-- |
About Advanced Enzyme Technologies Limited
Advanced Enzyme Technologies Limited, together with its subsidiaries, engages in the research, development, manufacture, and marketing of enzymes and probiotics in India, Europe, the United States, Asia, and internationally. The company offers enzymes and probiotics-based nutritional supplements for human healthcare and nutrition, animal nutrition, fruit and vegetable processing, baking, brewing … Read more